‘Exploring the PHF6-RRM2 axis as a novel entry point for targeted therapy in neuroblastoma using in vitro and in vivo modeling' - PhD defence

CRIG member Lisa Depestel is defending her doctoral thesis entitled ‘Exploring the PHF6-RRM2 axis as a novel entry point for targeted therapy in neuroblastoma using in vitro and in vivo modeling'.